BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33300816)

  • 1. Clinical significance of combining salivary mRNAs and carcinoembryonic antigen for ovarian cancer detection.
    Yang J; Xiang C; Liu J
    Scand J Clin Lab Invest; 2021 Feb; 81(1):39-45. PubMed ID: 33300816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of predictive role of carcinoembryonic antigen and salivary mRNA biomarkers in gastric cancer detection.
    Xu F; Jiang M
    Medicine (Baltimore); 2020 May; 99(22):e20419. PubMed ID: 32481437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma.
    Lee YH; Kim JH; Zhou H; Kim BW; Wong DT
    J Mol Med (Berl); 2012 Apr; 90(4):427-34. PubMed ID: 22095100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of circulating tumor cells and salivary mRNA to detect non-small-cell lung cancer.
    Gu X; He J; Ji G
    Medicine (Baltimore); 2020 Feb; 99(8):e19097. PubMed ID: 32080083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined use of salivary biomarkers and carcinoembryonic antigen for lung cancer detection in a Chinese population.
    Shang X; Zi H; Li Y; Gao Y; Ge C; Sun Z; Zhang Y
    Medicine (Baltimore); 2019 Aug; 98(31):e16511. PubMed ID: 31374012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and Saliva Levels of Cancer Antigen 15-3, Carcinoembryonic Antigen, Estradiol, Vaspin, and Obestatin as Biomarkers for the Diagnosis of Breast Cancer in Postmenopausal Women.
    Farahani H; Amri J; Alaee M; Mohaghegh F; Rafiee M
    Lab Med; 2020 Nov; 51(6):620-627. PubMed ID: 32537654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of blood and salivary IEX-1 expression in diagnosis of epithelial ovarian carcinoma.
    Li Y; Tan C; Liu L; Han L
    J Obstet Gynaecol Res; 2018 Apr; 44(4):764-771. PubMed ID: 29431239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Validation of Salivary Extracellular RNA Biomarkers for Noninvasive Detection of Gastric Cancer.
    Li F; Yoshizawa JM; Kim KM; Kanjanapangka J; Grogan TR; Wang X; Elashoff DE; Ishikawa S; Chia D; Liao W; Akin D; Yan X; Lee MS; Choi R; Kim SM; Kang SY; Bae JM; Sohn TS; Lee JH; Choi MG; Min BH; Lee JH; Kim JJ; Kim Y; Kim S; Wong DTW
    Clin Chem; 2018 Oct; 64(10):1513-1521. PubMed ID: 30097497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer.
    Zhang L; Xiao H; Karlan S; Zhou H; Gross J; Elashoff D; Akin D; Yan X; Chia D; Karlan B; Wong DT
    PLoS One; 2010 Dec; 5(12):e15573. PubMed ID: 21217834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of CA125/CEA ratio and ultrasound parameters in identifying metastases to the ovaries in patients with multilocular and multilocular-solid ovarian masses.
    Moro F; Pasciuto T; Djokovic D; Di Legge A; Granato V; Moruzzi MC; Mancari R; Zannoni GF; Fischerova D; Franchi D; Scambia G; Testa AC
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):116-123. PubMed ID: 29978587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multimarker assay for early detection of ovarian cancer.
    Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE
    J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer.
    Zhang L; Farrell JJ; Zhou H; Elashoff D; Akin D; Park NH; Chia D; Wong DT
    Gastroenterology; 2010 Mar; 138(3):949-57.e1-7. PubMed ID: 19931263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of Naa10p and CEA levels in saliva and serum for diagnosis of oral squamous cell carcinoma.
    Zheng J; Sun L; Yuan W; Xu J; Yu X; Wang F; Sun L; Zeng Y
    J Oral Pathol Med; 2018 Oct; 47(9):830-835. PubMed ID: 30028540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
    Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
    BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary transcriptome diagnostics for oral cancer detection.
    Li Y; St John MA; Zhou X; Kim Y; Sinha U; Jordan RC; Eisele D; Abemayor E; Elashoff D; Park NH; Wong DT
    Clin Cancer Res; 2004 Dec; 10(24):8442-50. PubMed ID: 15623624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
    Han C; Bellone S; Siegel ER; Altwerger G; Menderes G; Bonazzoli E; Egawa-Takata T; Pettinella F; Bianchi A; Riccio F; Zammataro L; Yadav G; Marto JA; Penet MF; Levine DA; Drapkin R; Patel A; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2018 Jun; 149(3):585-591. PubMed ID: 29572027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphological and phenotypical features of ovarian metastases in breast cancer patients.
    Peters IT; van der Steen MA; Huisman BW; Hilders CG; Smit VT; Vahrmeijer AL; Sier CF; Trimbos JB; Kuppen PJ
    BMC Cancer; 2017 Mar; 17(1):206. PubMed ID: 28327103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of salivary proteomic signatures for non-invasive detection of ovarian cancer.
    Tajmul M; Parween F; Singh L; Mathur SR; Sharma JB; Kumar S; Sharma DN; Yadav S
    Int J Biol Macromol; 2018 Mar; 108():503-514. PubMed ID: 29222021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CEA, Tag-72, and Lewis-Y antigen in primary and metastatic lesions of ovarian carcinoma.
    Chhieng DC; Rodriguez-Burford C; Talley LI; Sviglin H; Stockard CR; Kleinberg MJ; Barnes MN; Partridge EE; Khazaeli MB; Grizzle WE
    Hum Pathol; 2003 Oct; 34(10):1016-21. PubMed ID: 14608535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of LOCIā„¢-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.